Pathophysiological Mechanisms of Antipsychotic-Induced Parkinsonism.
antipsychotic-induced parkinsonism
antipsychotics
drug-induced parkinsonism
pathogenesis
pathophysiology
theories of pathogenesis
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
18 Aug 2022
18 Aug 2022
Historique:
received:
09
06
2022
revised:
25
07
2022
accepted:
10
08
2022
entrez:
26
8
2022
pubmed:
27
8
2022
medline:
27
8
2022
Statut:
epublish
Résumé
Among neurological adverse reactions in patients with schizophrenia treated with antipsychotics (APs), drug-induced parkinsonism (DIP) is the most common motility disorder caused by drugs affecting dopamine receptors. One of the causes of DIP is the disruption of neurotransmitter interactions that regulate the signaling pathways of the dopaminergic, cholinergic, GABAergic, adenosinergic, endocannabinoid, and other neurotransmitter systems. Presently, the development mechanisms remain poorly understood despite the presence of the considered theories of DIP pathogenesis.
Identifiants
pubmed: 36009557
pii: biomedicines10082010
doi: 10.3390/biomedicines10082010
pmc: PMC9405702
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Eur Neurol. 2012;67(1):4-11
pubmed: 22134373
Pharmacopsychiatry. 1995 Oct;28 Suppl 2:73-9
pubmed: 8614704
Neuropsychopharmacology. 2007 Aug;32(8):1840-54
pubmed: 17203014
East Mediterr Health J. 2001 May;7(3):559-61
pubmed: 12690781
Trends Neurosci. 1997 Oct;20(10):482-7
pubmed: 9347617
J Comp Neurol. 1974 Jun 15;155(4):469-81
pubmed: 4847734
Biol Pharm Bull. 2013;36(9):1396-400
pubmed: 23995648
Psychopharmacology (Berl). 2002 Aug;163(1):85-94
pubmed: 12185404
Schizophr Bull. 1989;15(1):123-9
pubmed: 2566199
Neuropharmacology. 2011 Feb-Mar;60(2-3):201-8
pubmed: 20813116
J Clin Neurol. 2012 Mar;8(1):15-21
pubmed: 22523509
Psychopharmacology (Berl). 2008 Oct;200(3):393-401
pubmed: 18594798
Am J Psychiatry. 2001 Mar;158(3):360-9
pubmed: 11229973
J Chem Neuroanat. 2005 Jan;29(1):21-30
pubmed: 15589699
Annu Rev Med. 2001;52:503-17
pubmed: 11160792
Peptides. 1983 May-Jun;4(3):393-5
pubmed: 6634474
Cell Signal. 2013 Dec;25(12):2863-70
pubmed: 24036210
Pharmacol Ther. 2012 Mar;133(3):324-33
pubmed: 22133841
Prog Neuropsychopharmacol Biol Psychiatry. 2001 Apr;25(3):573-90
pubmed: 11370998
Biol Psychiatry. 1981 Sep;16(9):831-5
pubmed: 7295843
Front Biosci. 2008 May 01;13:3594-605
pubmed: 18508458
Proc Natl Acad Sci U S A. 2009 Dec 15;106(50):21377-82
pubmed: 19948956
Semin Neurol. 2001;21(1):59-68
pubmed: 11346026
Am J Psychiatry. 1991 Oct;148(10):1322-8
pubmed: 1680296
Synapse. 1996 Feb;22(2):132-8
pubmed: 8787129
Eur Neuropsychopharmacol. 2013 Aug;23(8):887-94
pubmed: 22980146
Pharmacopsychiatry. 2005 Jul;38(4):171-7
pubmed: 16025420
South Med J. 1990 May;83(5):525-32
pubmed: 1971459
Int Clin Psychopharmacol. 2006 Mar;21(2):127-9
pubmed: 16421466
Expert Opin Drug Saf. 2006 Nov;5(6):759-71
pubmed: 17044803
Schizophr Res. 2009 Feb;107(2-3):206-12
pubmed: 18789844
Neuropsychobiology. 2001;44(3):126-8
pubmed: 11586051
Pol J Pharmacol. 2002 Jul-Aug;54(4):299-312
pubmed: 12523484
Neurotox Res. 2002 Feb;4(1):51-8
pubmed: 12826493
Neurol Ther. 2018 Dec;7(2):233-248
pubmed: 30027457
Neuroscience. 2013 Apr 16;236:77-87
pubmed: 23352937
J Parkinsons Dis. 2013;3(4):547-55
pubmed: 24081441
Maturitas. 2014 May;78(1):40-4
pubmed: 24685289
Prog Neuropsychopharmacol Biol Psychiatry. 2010 Aug 16;34(6):877-81
pubmed: 20398719
J Biol Chem. 2008 Jul 11;283(28):19301-13
pubmed: 18474595
Neuropharmacology. 2008 Oct;55(5):717-23
pubmed: 18585397
Cell Mol Neurobiol. 2005 Jun;25(3-4):553-80
pubmed: 16075379
J Pineal Res. 1986;3(4):379-88
pubmed: 3783419
Int J Neurosci. 1992 May-Jun;64(1-4):203-7
pubmed: 1364141
BMJ Neurol Open. 2020 Jan 27;2(1):e000034
pubmed: 33681781
Pol J Pharmacol. 1997 Aug;49(4):213-9
pubmed: 9437764
Curr Drug Metab. 2013 Nov;14(9):989-93
pubmed: 24160295
Pharmacol Rep. 2007 Mar-Apr;59(2):181-91
pubmed: 17556796
Neuropharmacology. 1999 Aug;38(8):1083-152
pubmed: 10462127
Psychopharmacology (Berl). 2010 Jan;208(1):131-41
pubmed: 19936716
Arch Gen Psychiatry. 1992 Jul;49(7):538-44
pubmed: 1352677
Neurosci Biobehav Rev. 2011 Jan;35(3):878-93
pubmed: 20974172
JAMA. 1961 Mar 25;175:1054-60
pubmed: 13685365
Synapse. 2001 Aug;41(2):160-71
pubmed: 11400182
Schizophr Bull. 1991;17(2):263-87
pubmed: 1679253
J Exp Pharmacol. 2016 Aug 08;8:1-10
pubmed: 27540314
Biol Psychiatry. 1988 Feb 15;23(4):405-25
pubmed: 3277676
Acta Neuropathol. 1978 Apr 26;42(1):49-52
pubmed: 654878
Drug Chem Toxicol. 2015 Oct;38(4):415-27
pubmed: 25367720
J Mol Neurosci. 2005;26(2-3):209-20
pubmed: 16012194
Mov Disord. 2008 Feb 15;23(3):401-4
pubmed: 18067180
J Pharmacol Sci. 2009 Apr;109(4):593-9
pubmed: 19352073
Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(7):47-51
pubmed: 23994921
Hum Psychopharmacol. 2008 Jan;23 Suppl 1:15-26
pubmed: 18098217
CNS Neurosci Ther. 2011 Feb;17(1):58-65
pubmed: 21091640
Biomedicines. 2021 Jul 23;9(8):
pubmed: 34440083
Recent Pat CNS Drug Discov. 2007 Jan;2(1):1-21
pubmed: 18221214
J Neurophysiol. 2007 Oct;98(4):2311-23
pubmed: 17715194
Neurosci Lett. 2014 Feb 21;561:74-9
pubmed: 24394913
Arch Gen Psychiatry. 1974 Jul;31(1):58-61
pubmed: 4152054
J Psychopharmacol. 2005 May;19(3):277-85
pubmed: 15888513
Neurol Clin. 2011 Feb;29(1):127-48, viii
pubmed: 21172575
J Pharmacol Exp Ther. 1993 Apr;265(1):207-17
pubmed: 8386235
Curr Treat Options Neurol. 2009 May;11(3):162-9
pubmed: 19364450
Neuron. 2014 Jan 8;81(1):153-64
pubmed: 24411738
Eur Neuropsychopharmacol. 2006 Oct;16(7):491-7
pubmed: 16500086
Acta Psychiatr Scand. 1994 Oct;90(4):266-8
pubmed: 7831996
Drug Metab Dispos. 2003 Mar;31(3):243-9
pubmed: 12584149
Eur J Pharmacol. 2008 Aug 20;590(1-3):241-5
pubmed: 18590723
Neurosciences (Riyadh). 2013 Jul;18(3):215-21
pubmed: 23887211
Mol Neurobiol. 1996 Feb;12(1):73-94
pubmed: 8732541
Neuropharmacology. 1999 Jan;38(1):151-6
pubmed: 10193906
Neurosci Lett. 2004 Nov 30;372(1-2):157-60
pubmed: 15531108
J Neurochem. 1995 Nov;65(5):2057-64
pubmed: 7595490
Schizophr Res. 2006 Dec;88(1-3):102-10
pubmed: 16959472
Front Neuroanat. 2010 Dec 10;4:133
pubmed: 21179580
Prog Neuropsychopharmacol Biol Psychiatry. 2012 Aug 7;38(2):252-9
pubmed: 22542492
Nat Rev Neurosci. 2016 Aug;17(8):524-32
pubmed: 27256556
Arch Neurol. 1962 Jan;6:5-9
pubmed: 14477743
Handb Exp Pharmacol. 2009;(193):471-534
pubmed: 19639292
Int J Neuropsychopharmacol. 1998 Dec;1(2):95-101
pubmed: 11281952
Arch Gen Psychiatry. 2003 Oct;60(10):974-7
pubmed: 14557141
Ann Clin Psychiatry. 1994 Jun;6(2):67-78
pubmed: 7804391
Metab Brain Dis. 2014 Jun;29(2):541-51
pubmed: 24242214
Can J Psychiatry. 2005 Aug;50(9):541-7
pubmed: 16262110
Clin Neuropharmacol. 1993 Feb;16(1):90-5
pubmed: 8093682
J Neural Transm (Vienna). 2004 Jun;111(6):667-81
pubmed: 15168214
Eur J Pharmacol. 2006 Dec 15;552(1-3):55-66
pubmed: 17064683
J Comp Neurol. 2001 Mar 12;431(3):331-46
pubmed: 11170009
Parkinsonism Relat Disord. 2009 Jul;15(6):406-13
pubmed: 19446490
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jul 1;32(5):1302-7
pubmed: 18495311
Dokl Biol Sci. 2012 May-Jun;444:144-6
pubmed: 22760610
Biochem Biophys Res Commun. 2012 Aug 24;425(2):426-30
pubmed: 22846577
Neuroscience. 1994 Apr;59(3):625-40
pubmed: 7516506